Automation is to play a key role in transforming regulatory processes in life sciences, but is AI being oversold by business process delivery partners? Alan White, CEO of Arriello, warns that focussed application is essential to delivering results.
The rise of artificial intelligence has been popular within the life sciences industry and in particular pharma. Find out why and what it means for the future of drug development.
Gero Lustig, global business manager Pharma and Life Sciences at ABB explains how using a digital twin of existing machines can determine how best to implement shop floor integration prior to installation.
Rod Schregardus, supply chain technology specialist at Access Group, discusses the role of advanced planning and scheduling (APS) systems in pharmaceuticals manufacturing.
Justin Schroeder, vice president for global programme management at PCI Pharma Services, looks at how to support the delivery of biologics through automated inspection systems.
Dr Niklas Sandler, chief technology officer at Nanoform, explains why the use of nanonisation and artificial intelligence (AI) can help pharmaceutical manufacturers unlock added value for bioavailable nanoparticles.
Jonathan Wilkins, marketing director of obsolete industrial parts supplier EU Automation, explains how biopharmaceutical plants can benefit from automation.
